Terry Murdock Net Worth & Insider Trades
Terry Murdock - Chief Operating Officer, G1 Therapeutics, Inc
What is Terry Murdock's Net Worth?
The current estimated net worth of G1 Therapeutics, Inc's Chief Operating Officer, Terry Murdock, is estimated to be about $1M . Terry Murdock owns about 36,439 units of G1 Therapeutics, Inc common stock. In the last 6 years at G1 Therapeutics, Inc, Terry Murdock has sold an estimated value of $875.86K worth.
What is Terry Murdock's Past Insider Trading?
Terry Murdock's largest purchase order was 3,523 units , worth over $47.6K on December 3, 2018. Terry Murdock's largest sale order was 3,519 units , worth over $211.06K on September 6, 2018. In total, Terry Murdock has made about 14 transactions over 6 years of their time at G1 Therapeutics, Inc. Terry Murdock usually trades in January, with the busiest year in 2018. The most recent transaction was a sale order of 2,368 units , worth over $13.08K on January 5, 2023.
TERRY MURDOCK
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
G1 Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| John E. Bailey, Jr. | 2020 | - | $542,109 | - | $215,948 | $758,057 |
| Mark A. Velleca, M.D., Ph.D. | 2020 | $608,308 | $3,069,704 | $305,000 | $8,550 | $3,991,562 |
| Mark A. Velleca, M.D., Ph.D. | 2019 | $589,700 | $3,105,237 | $280,108 | $8,400 | $3,983,445 |
| Mark A. Velleca, M.D., Ph.D. | 2018 | $515,000 | $1,044,529 | $321,875 | $33,250 | $1,914,654 |
| Jennifer K. Moses | 2020 | $398,583 | $1,116,239 | $141,050 | $8,550 | $1,664,422 |
| Jennifer K. Moses | 2019 | $315,598 | $972,601 | $117,600 | $8,400 | $1,414,199 |
| Mark Avagliano | 2020 | $431,417 | $837,165 | $151,200 | $18,445 | $1,438,227 |
| Mark Avagliano | 2019 | $181,913 | $5,100,560 | $142,800 | $53,117 | $5,478,390 |
| Rajesh K. Malik, M.D. | 2020 | $424,000 | $836,733 | $148,750 | $8,550 | $1,418,033 |
| Rajesh K. Malik, M.D. | 2019 | $413,000 | $828,195 | $138,768 | $8,400 | $1,388,363 |
| Rajesh K. Malik, M.D. | 2018 | $400,000 | $696,968 | $169,400 | $8,250 | $1,274,618 |
| Soma Gupta | 2020 | $320,360 | $2,212,758 | $114,662 | $100,000 | $2,747,780 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1560241/000119312521136977/d122680ddef14a.htm
What are G1 Therapeutics, Inc's Past Insider Trades?
G1 Therapeutics, Inc's most recent insider trade came on January 5, 2023 by Jennifer Moses who sold 2,368 units worth $13.08K . In the last 6 years, insiders at G1 Therapeutics, Inc have sold an estimated value of $69.69M and bought an estimated value of $25.76M worth of shares. Insider trading is most common in January, with the busiest year in 2018. The most active traders at the company are Rajesh Malik, Chief Medical Officer, Mark Velleca, and Jennifer Moses, CFO .
G1 Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||